Evotec SE (EVO) EBITDA Margin (2020 - 2025)

Evotec SE's (EVO) quarterly EBITDA Margin came in at 22.9% in Q4 2025, up 1001.0% year-on-year from 2.08% in Q4 2024, and up 184.33% quarter-over-quarter from 27.15% in Q3 2025.

Evotec SE (EVO) EBITDA Margin (2020 - 2025) Analysis & Trends

Evotec SE has disclosed EBITDA Margin across 6 years of filings, most recently posting 22.9% for Q4 2025.

  • EBITDA Margin for Q4 2025 came in at 22.9%, up 1001.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1.82% (down 356.0% YoY), and the FY2025 annual result was 0.01%, down 283563.0% from the prior year.
  • EBITDA Margin came in at 22.9% for Q4 2025 at Evotec SE, up from 27.15% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 22.9% in Q4 2025 to a low of 27.15% in Q3 2025.
  • The 5-year median for EBITDA Margin is 8.66% (2023), against an average of 3.86%.
  • Across the five-year window, EBITDA Margin plunged 2126860 bps in 2021 and surged 1001 bps in 2025, its largest moves.
  • Evotec SE's EBITDA Margin stood at 16.26% in 2021, then tumbled by 46 bps to 8.73% in 2022, then retreated by 1 bps to 8.66% in 2023, then soared by 49 bps to 12.88% in 2024, then soared by 78 bps to 22.9% in 2025.
  • The last three EBITDA Margin figures came in at 22.9% (Q4 2025), 27.15% (Q3 2025), and 12.88% (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 16.37%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 36.83%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -1.01%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 22.74%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 22.39%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -170.35%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 21.55%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -16.25%
10 Evotec SE 583.10 Mn 582.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 22.90%
Sep 30, 2025 -27.15%
Dec 31, 2024 12.88%
Sep 30, 2024 -14.33%
Dec 31, 2023 8.66%
Sep 30, 2023 6.21%
Jun 30, 2023 -21.31%
Dec 31, 2022 8.73%
Sep 30, 2022 7.78%
Jun 30, 2022 -2.19%
Mar 31, 2022 11.45%
Dec 31, 2021 16.26%
Sep 30, 2021 11.11%
Jun 30, 2021 1.11%
Mar 31, 2021 15.86%
Dec 31, 2020 21,284.87%